cromolyn sodium has been researched along with Lipodystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldfine, AB; Lopez, X; Phua, EJ; Ramus, J | 1 |
| Castells, M; Goldfine, AB; Lopez, X; Mun, E; Ricker, A; Velazquez, EF | 1 |
2 other study(ies) available for cromolyn sodium and Lipodystrophy
| Article | Year |
|---|---|
Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
Topics: Adolescent; Anti-Asthmatic Agents; Cromolyn Sodium; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulins; Lipodystrophy; Male; Young Adult | 2013 |
Human insulin analog--induced lipoatrophy.
Topics: Adolescent; Adult; Child; Child, Preschool; Chymases; Cromolyn Sodium; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Lipodystrophy; Mast Cells; Tryptases | 2008 |